Abstract:Circulatory changes with increased blood flow and vasodilatation/vasoconstriction imbalance are an integral consequence of liver cirrhosis and portal hypertension and can affect the pulmonary circulation with the development of vascular disorders, with hepatopulmonary syndrome (HPS) being the most common. HPS is a serious pulmonary complication of progressive liver disease, resulting in a poor clinical prognosis. Vascular tone decrease, monocytic infiltration of pulmonary vessels, formation of intrapulmonary arteriovenous shunts, dysfunction of alveolar type II cells, destruction of the endothelial glycocalyx are important in the pathogenesis of HPS. Abnormalities of pulmonary capillaries lead to hypoxemia caused by a violation of the ventilation/perfusion ratio, diffusion disorders, and the development of arteriovenous anastomoses. Infiltration of the pulmonary vessels by monocytes is one of the key factors of HPS. This migration is facilitated by the intestinal microbiota translocation into the portal bloodstream with increased expression of proinflammatory cytokines (tumor necrosis factor α, interleukins 1, 6), leading to the activation of monocytes. Monocytes located in the pulmonary circulation promote the vasodilation through the activation of inducible nitric oxide (NO) synthase and thus NO production. This is also associated with endothelial dysfunction due to a decreased hepatic secretion of bone morphogenetic protein 9 and increased endothelin 1, endothelial overexpression of endothelin B receptors, and increased endothelial NO production. Proangiogenic factors such as vascular endothelial growth factor, platelet-derived growth factor, and placental growth factor play an important role in the proliferation of pulmonary capillaries. Circulation of tumor necrosis factor α, bile acids and monocyte infiltration in the pulmonary circulation lead to increased apoptosis of alveolar type II cells and decreased surfactant synthesis. Chronic inflammation in HPS disrupts the continuity of the endothelial glycocalyx layer. This article provides an overview of the current knowledge on the pathogenesis of HPS, summarizes many features of the disease based on the literature research in MEDLINE database on the PubMed platform.

The pulmonary manifestation of hepatopulmonary syndrome presented by CT and DSA based on pathologic changes

Multi-slice CT Study of Intrapulmonary Vascular Changes in HPS

Diagnosis and management of hepatopulmonary syndrome

Hepatopulmonary Syndrome: the Role of Intra-Abdominal Hypertension and A Novel Mouse Model

Role of vascular mediators in the pathogenesis of hepatopulmonary syndrome in rats

Progress in investigating the pathogenesis of hepatopulmonary syndrome.

Measurement Study of Intrapulmonary Vascular Changes on HPS

Measurement of Intrapulmonary Vascular Changes in Hepatopulmonary Syndrome with 16-Slice CT Volume Measuring

Significance of Lung Perfusion Scanning with Technetium Labeled Macroaggregated Albumin and Pulmonary Function Assay for Diagnosis of Early Hepatopulmonary Syndrome

Changes of serum cytokines and pulmonary intravascular macrophages in rats with hepatopulmonary syndrome

Hepatopulmonary Syndrome: A Comprehensive Review

[Lung Expression of Tissue Factor Mrna and Its Significance in a Rat Model of Hepatopulmonary Syndrome].

Pathophysiological basis of hepatopulmonary syndrome

Computer Tomographic Assessment of Partial Liquid Ventilation in Dogs with Inhalation Injury

Effects of Partial Liquid Ventilation(plv)on Histopathology of Dog's Lung with Inhalation Injury

The association of lipopolysaccharide and inflammatory factors with hepatopulmonary syndrome and their changes after orthotopic liver transplantation.

Hepatopulmonary Syndrome Delays Postoperative Recovery and Increases Pulmonary Complications after Hepatectomy

The role of orthotopic liver transplantation in hepatopulmonary syndrome

[Significance of Lipopolysaccharides, Toll-Like Receptor and Inducible Nitric Oxide Synthase in Hepatopulmonary Syndrome].

Hepatopulmonary syndrome: Case report of the evidence of intrapulmonary shunt on 99mTc-MAA scintigraphy and contrast transthoracic echocardiography

Correlation Analysis Between Hypoxia-Inducible Factor-1Α Gene Polymorphism and Hepatopulmonary Syndrome